These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 19131406)

  • 1. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2.
    Mittal S; Wu Z; Neelavalli J; Haacke EM
    AJNR Am J Neuroradiol; 2009 Feb; 30(2):232-52. PubMed ID: 19131406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1.
    Haacke EM; Mittal S; Wu Z; Neelavalli J; Cheng YC
    AJNR Am J Neuroradiol; 2009 Jan; 30(1):19-30. PubMed ID: 19039041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility-weighted Imaging: Technical Essentials and Clinical Neurologic Applications.
    Haller S; Haacke EM; Thurnher MM; Barkhof F
    Radiology; 2021 Apr; 299(1):3-26. PubMed ID: 33620291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility weighted magnetic resonance sequences "SWAN, SWI and VenoBOLD": technical aspects and clinical applications].
    Hodel J; Rodallec M; Gerber S; Blanc R; Maraval A; Caron S; Tyvaert L; Zuber M; Zins M
    J Neuroradiol; 2012 May; 39(2):71-86. PubMed ID: 22342939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility-weighted imaging in pediatric neuroimaging.
    Bosemani T; Poretti A; Huisman TA
    J Magn Reson Imaging; 2014 Sep; 40(3):530-44. PubMed ID: 24925729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STrategically Acquired Gradient Echo (STAGE) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method.
    Haacke EM; Chen Y; Utriainen D; Wu B; Wang Y; Xia S; He N; Zhang C; Wang X; Lagana MM; Luo Y; Fatemi A; Liu S; Gharabaghi S; Wu D; Sethi SK; Huang F; Sun T; Qu F; Yadav BK; Ma X; Bai Y; Wang M; Cheng J; Yan F
    Magn Reson Imaging; 2020 Jan; 65():15-26. PubMed ID: 31629075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.
    Liu C; Li W; Tong KA; Yeom KW; Kuzminski S
    J Magn Reson Imaging; 2015 Jul; 42(1):23-41. PubMed ID: 25270052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Susceptibility Mapping: Concepts and Applications.
    Reichenbach JR; Schweser F; Serres B; Deistung A
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():225-30. PubMed ID: 26198880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility-weighted imaging: clinical angiographic applications.
    Barnes SR; Haacke EM
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):47-61. PubMed ID: 19364599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T.
    Kang H; Jang S
    Acta Radiol; 2021 Jun; 62(6):791-798. PubMed ID: 32664747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility-weighted imaging: current status and future directions.
    Liu S; Buch S; Chen Y; Choi HS; Dai Y; Habib C; Hu J; Jung JY; Luo Y; Utriainen D; Wang M; Wu D; Xia S; Haacke EM
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27192086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of susceptibility-weighted and perfusion-weighted magnetic resonance imaging in the detection of penumbra in acute ischemic stroke.
    Luo S; Yang L; Wang L
    J Neuroradiol; 2015 Oct; 42(5):255-60. PubMed ID: 25451668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a 2D multibreath-hold susceptibility-weighted imaging to visualize intratumoral hemorrhage of hepatocellular carcinoma at 3T MRI: correlation with pathology.
    Li RK; Zeng MS; Rao SX; Qiang JW; Dai YM; Ji Y; Chen CZ; Renate J
    J Magn Reson Imaging; 2012 Oct; 36(4):900-6. PubMed ID: 22744981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility-Weighted Imaging in Neurodegenerative Disorders: A Review.
    Sotoudeh H; Sarrami AH; Wang JX; Saadatpour Z; Razaei A; Gaddamanugu S; Choudhary G; Shafaat O; Singhal A
    J Neuroimaging; 2021 May; 31(3):459-470. PubMed ID: 33624404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance susceptibility weighted imaging in neurosurgery: current applications and future perspectives.
    Di Ieva A; Lam T; Alcaide-Leon P; Bharatha A; Montanera W; Cusimano MD
    J Neurosurg; 2015 Dec; 123(6):1463-75. PubMed ID: 26207600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of T2*-weighted gradient-echo MRI for the diagnosis of cerebral venous sinus thrombosis.
    Ihn YK; Jung WS; Hwang SS
    Clin Imaging; 2013; 37(3):446-50. PubMed ID: 23068055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?
    Aydın Ö; Büyükkaya R; Hakyemez B
    Acta Radiol; 2017 Jan; 58(1):107-113. PubMed ID: 26966145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced techniques using contrast media in neuroimaging.
    Ferré JC; Shiroishi MS; Law M
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):699-713. PubMed ID: 23088946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical applications of 3.0 T magnetic resonance system in the neuroradiological field].
    Matsusue E; Ogawa T
    Brain Nerve; 2007 May; 59(5):479-85. PubMed ID: 17533973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting.
    Eissa A; Lebel RM; Korzan JR; Zavodni AE; Warren KG; Catz I; Emery DJ; Wilman AH
    J Magn Reson Imaging; 2009 Oct; 30(4):737-42. PubMed ID: 19787716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.